156 related articles for article (PubMed ID: 16702945)
1. Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist.
Yan H; Thomas J; Liu T; Raj D; London N; Tandeski T; Leachman SA; Lee RM; Grossman D
Oncogene; 2006 Nov; 25(52):6968-74. PubMed ID: 16702945
[TBL] [Abstract][Full Text] [Related]
2. Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.
Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
Protein Expr Purif; 2006 May; 47(1):36-44. PubMed ID: 16260148
[TBL] [Abstract][Full Text] [Related]
3. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.
Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
J Biotechnol; 2006 May; 123(3):367-78. PubMed ID: 16406157
[TBL] [Abstract][Full Text] [Related]
4. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells.
Liu T; Brouha B; Grossman D
Oncogene; 2004 Jan; 23(1):39-48. PubMed ID: 14712209
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
[TBL] [Abstract][Full Text] [Related]
6. A single amino acid change (Asp 53 --> Ala53) converts Survivin from anti-apoptotic to pro-apoptotic.
Song Z; Liu S; He H; Hoti N; Wang Y; Feng S; Wu M
Mol Biol Cell; 2004 Mar; 15(3):1287-96. PubMed ID: 14699067
[TBL] [Abstract][Full Text] [Related]
7. Pro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cells.
Shen C; Liu W; Buck AK; Reske SN
Anticancer Res; 2009 Apr; 29(4):1423-8. PubMed ID: 19414397
[TBL] [Abstract][Full Text] [Related]
8. Cancer gene therapy using a survivin mutant adenovirus.
Mesri M; Wall NR; Li J; Kim RW; Altieri DC
J Clin Invest; 2001 Oct; 108(7):981-90. PubMed ID: 11581299
[TBL] [Abstract][Full Text] [Related]
9. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential.
Khan S; Aspe JR; Asumen MG; Almaguel F; Odumosu O; Acevedo-Martinez S; De Leon M; Langridge WH; Wall NR
Br J Cancer; 2009 Apr; 100(7):1073-86. PubMed ID: 19293795
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].
Zheng WY; Ma XY; Wei DZ; Wang JZ; Liu QH; Ma YS; Yang SL
Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):285-92. PubMed ID: 16607958
[TBL] [Abstract][Full Text] [Related]
11. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.
Ferrario A; Rucker N; Wong S; Luna M; Gomer CJ
Cancer Res; 2007 May; 67(10):4989-95. PubMed ID: 17510430
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.
Wang Z; Sampath J; Fukuda S; Pelus LM
Cancer Res; 2005 Sep; 65(18):8224-32. PubMed ID: 16166298
[TBL] [Abstract][Full Text] [Related]
13. Multisite mutation of monomer survivin with enhanced effect on apoptosis regulation of breast cancer cells.
Dai G; Zheng W; Ma X; Wang P
Biomed Pharmacother; 2015 Feb; 69():111-8. PubMed ID: 25661346
[TBL] [Abstract][Full Text] [Related]
14. Survivin-responsive conditionally replicating adenovirus kills rhabdomyosarcoma stem cells more efficiently than their progeny.
Tanoue K; Wang Y; Ikeda M; Mitsui K; Irie R; Setoguchi T; Komiya S; Natsugoe S; Kosai K
J Transl Med; 2014 Jan; 12():27. PubMed ID: 24467821
[TBL] [Abstract][Full Text] [Related]
15. Suppression of tumor growth using antisense oligonucleotide against survivin in an orthotopic transplant model of human hepatocellular carcinoma in nude mice.
Sun Y; Lin R; Dai J; Jin D; Wang SQ
Oligonucleotides; 2006; 16(4):365-74. PubMed ID: 17155911
[TBL] [Abstract][Full Text] [Related]
16. Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication.
Kamizono J; Nagano S; Murofushi Y; Komiya S; Fujiwara H; Matsuishi T; Kosai K
Cancer Res; 2005 Jun; 65(12):5284-91. PubMed ID: 15958575
[TBL] [Abstract][Full Text] [Related]
17. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.
Grossman D; McNiff JM; Li F; Altieri DC
J Invest Dermatol; 1999 Dec; 113(6):1076-81. PubMed ID: 10594755
[TBL] [Abstract][Full Text] [Related]
18. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
Hou JQ; He J; Wang XL; Wen DG; Chen ZX
Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
[TBL] [Abstract][Full Text] [Related]
19. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy.
Kanwar JR; Shen WP; Kanwar RK; Berg RW; Krissansen GW
J Natl Cancer Inst; 2001 Oct; 93(20):1541-52. PubMed ID: 11604477
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of melanoma tumor growth in vivo by survivin targeting.
Grossman D; Kim PJ; Schechner JS; Altieri DC
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):635-40. PubMed ID: 11149963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
